GUERRA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 8.390
AS - Asia 4.402
EU - Europa 4.061
SA - Sud America 666
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 17.600
Nazione #
US - Stati Uniti d'America 8.172
SG - Singapore 1.422
IT - Italia 1.119
VN - Vietnam 1.089
CN - Cina 987
DE - Germania 626
RU - Federazione Russa 583
BR - Brasile 551
HK - Hong Kong 515
SE - Svezia 466
IE - Irlanda 345
GB - Regno Unito 217
UA - Ucraina 197
CA - Canada 164
IN - India 94
FR - Francia 91
FI - Finlandia 85
AT - Austria 81
DK - Danimarca 59
AR - Argentina 46
JP - Giappone 42
KR - Corea 42
MX - Messico 39
PL - Polonia 38
NL - Olanda 36
TR - Turchia 36
BD - Bangladesh 34
ID - Indonesia 31
IQ - Iraq 28
ZA - Sudafrica 28
BE - Belgio 27
EC - Ecuador 25
ES - Italia 22
CZ - Repubblica Ceca 18
BG - Bulgaria 15
KE - Kenya 11
VE - Venezuela 11
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 8
IR - Iran 8
PY - Paraguay 8
CO - Colombia 7
SA - Arabia Saudita 7
TN - Tunisia 7
PE - Perù 6
RO - Romania 6
UY - Uruguay 6
AU - Australia 5
CL - Cile 5
EU - Europa 5
IL - Israele 5
KG - Kirghizistan 5
MA - Marocco 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
JO - Giordania 4
LT - Lituania 4
OM - Oman 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HU - Ungheria 3
LK - Sri Lanka 3
MK - Macedonia 3
NI - Nicaragua 3
AL - Albania 2
GR - Grecia 2
HN - Honduras 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
SC - Seychelles 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GD - Grenada 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
PA - Panama 1
RE - Reunion 1
RS - Serbia 1
SN - Senegal 1
Totale 17.597
Città #
Ann Arbor 1.819
Singapore 909
Ashburn 744
Fairfield 557
Hong Kong 504
Woodbridge 461
Chandler 444
Houston 402
Wilmington 397
Milan 357
Ho Chi Minh City 340
Dublin 332
Frankfurt am Main 320
Dearborn 248
Hanoi 243
Seattle 235
New York 218
Jacksonville 199
Cambridge 177
Santa Clara 176
Beijing 159
Los Angeles 144
Princeton 134
Dallas 117
Lissone 104
Shanghai 103
Hefei 89
The Dalles 77
Nanjing 76
Vienna 63
Lawrence 61
São Paulo 59
Altamura 52
Moscow 49
Munich 49
Guangzhou 46
Buffalo 44
Chicago 44
Falls Church 43
London 42
San Diego 42
Da Nang 38
Fremont 38
Seoul 37
Tokyo 36
Helsinki 35
Lachine 30
Shenyang 29
Warsaw 29
Boardman 28
Jinan 28
Montreal 28
Council Bluffs 27
Nanchang 27
Dong Ket 26
Toronto 25
Haiphong 24
Nuremberg 24
Poplar 24
Brussels 23
Jakarta 23
Monza 22
Ha Long 21
Hải Dương 21
Ottawa 21
Thái Nguyên 20
Vancouver 20
Brooklyn 19
Bắc Ninh 19
Andover 18
Biên Hòa 18
Chennai 18
Hebei 17
Vũng Tàu 17
Johannesburg 16
Ninh Bình 16
Segrate 16
Stockholm 16
Boston 15
Genoa 15
Kunming 15
Orem 15
Rio de Janeiro 15
Salt Lake City 15
Atlanta 14
Brno 14
Bắc Giang 14
Manchester 14
Turku 14
Bari 13
Columbus 13
Plovdiv 13
Pune 13
Tampa 13
Amsterdam 12
Edmonton 12
Quận Bình Thạnh 12
Tianjin 12
Querétaro 11
Rome 11
Totale 11.868
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 691
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 478
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? 440
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 415
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 404
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 387
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 378
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 370
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 350
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 317
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 316
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 312
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 308
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 307
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 307
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 300
Respiratory motion management in PET/CT: applications and clinical usefulness 300
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 295
Motion management in PET/CT: Technological solutions 294
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 290
Erratum: ☆Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)) 280
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 278
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 272
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 270
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 269
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica 263
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 263
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 262
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 260
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 257
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 254
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 252
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 249
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 248
Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer 248
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 247
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 246
Lung Regional Metabolic Activity and Gas Volume Changes Induced by Tidal Ventilation in Patients with Acute Lung Injury 236
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement? 229
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 229
A case of Melas (A3243G) on chronic dichloroacetate treatment 217
Italian Multicenter Study on Accuracy of 18 F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 216
Imaging of lung inflammation during severe influenza A: H1N1 214
Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards 211
Focal bone lesions in hiv-positive patient treated with tenofovir 210
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 207
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 205
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 205
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases 198
Tidal changes on CT and progression of ARDS 194
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 194
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 189
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 189
FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial 189
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 186
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial 182
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study 177
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 166
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) 162
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 161
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 150
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease 140
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial 139
Respiratory Gating and the performance of PET/CT in pulmonary lesions 139
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation 137
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial 134
The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma) 122
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 113
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 105
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases 98
Prognostic value of PET-CT after fi rst-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies 97
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi 93
Immunoscintigraphy of ovarian cancer recurrences: comparison with surgical findings and CT scan or US results 91
Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review 84
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial 83
Current status of FDG-PET/CT in staging of adult lymphoma 78
Is there a role for metabolic imaging in pediatric non-Hodgkin lymphoma? 55
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 27
Totale 18.128
Categoria #
all - tutte 57.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.319 0 0 0 0 0 195 178 231 171 199 150 195
2021/20221.250 140 159 142 109 69 81 68 57 54 117 98 156
2022/20231.791 180 513 168 199 100 276 9 112 121 52 42 19
2023/20241.211 38 40 58 59 140 309 253 56 77 20 13 148
2024/20252.834 145 338 207 119 196 150 195 111 235 462 248 428
2025/20264.827 1.480 548 617 880 952 350 0 0 0 0 0 0
Totale 18.128